Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Post by Insightful1on Aug 12, 2021 11:06pm
315 Views
Post# 33699135

Sylvain Desjeans new CEO

Sylvain Desjeans new CEOhttps://stockhouse.com/news/press-releases/2021/08/12/medx-health-corp-appoints-sylvain-desjeans-as-chief-executive-officer

My take is as follows, Sylvain came to MedX with a very impressive background in the medical space and had strong leadership skills as demonstrated by the companies he led in the past. He started as a Chief Revenue Officer at MedX which gave him some time to assess MedX's business strategy, the existing team and the overall technology platform. 
The Board of Directors conducted an extensive search to find a President and CEO and after consideration Sylvain was chosen to lead MedX. What it tells me is he must believe in the strategy,the team and the technolgy platform and more importantly that he can lead this company forward. He brings a lot of connections and insight into this MedX that was missing. 

I suspect he will do the rounds and meet with the key stakeholders as well as a few podcasts so people can ask him what he sees in MedX and what is his vision. 

Robert von der Porten was only the acting CEO while they found a proper replacement so now it is up to Sylvain to lead this company.

I would also note that Empower gave an update and featured MedX in their update.

https://stockhouse.com/news/press-releases/2021/08/11/empower-clinics-provides-corporate-update-on-national-clinic-expansion


<< Previous
Bullboard Posts
Next >>